Pharmacists in Clintwood, Virginia


12 Pharmacists found in Clintwood
female pharmacist

Dr. Amy Meade, PHARMD


Pharmacist
342 Main Street, Clintwood, VA 24228
276-926-6707    

female pharmacist

Blakelee Suzanne Coleman, PHARMD


Pharmacist
410 Chase St, Clintwood, VA 24228
276-926-6002    

male pharmacist

David J. Deel, PHARM.D.


Pharmacist
Hwy 83 And Brush Creek, Clintwood, VA 24228
276-926-6555     276-926-6602



male pharmacist

Howard Robinson, PHARMD.


Pharmacist
100 Chase Street, 100 Chase Street, Clintwood, VA 24228
276-926-6002     276-926-6031

male pharmacist

Dr. Jonathan K Sutherland, PHARM D


Pharmacist
Rite Aid #1396, Corner Of Hwy 83 & Brush Creek Rd, Clintwood, VA 24228
276-926-6555     276-926-6602

female pharmacist

Leann Marie Yates, PHARM D.


Pharmacist
100 Chase Street, Clintwood, VA 24228
276-926-6002    

female pharmacist

Lisa M Howard, PHARMD


Pharmacist
Corner Of Route 83 And Brushcreek Road, Clintwood, VA 24228
276-926-6555    

male pharmacist

Patrick Deel, PHARM.D


Pharmacist
Highway 83 And Brushcreek, Clintwood, VA 24228
276-926-6555    

male pharmacist

Mr. Rexx Allen Baker, R.PH.


Pharmacist
#1 Main Street, Jettie Baker Bldg., Clintwood, VA 24228
276-926-6707    

female pharmacist

Sheryl Dawn Pientka, RPH


Pharmacist
342 Main St, Clintwood, VA 24228
276-926-6707     276-926-4482

male pharmacist

Timothy Patrick Mccarty, PHARMD


Pharmacist
340 Colley Shopping Ctr, Clintwood, VA 24228
276-926-6890     276-926-6893

male pharmacist

Travis W Garrett


Pharmacist
342 Main Street, Clintwood, VA 24228
276-926-6707     276-926-4482


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.